BIOMAT Database Logo BIOMAT Database Logo

A new pattern of cytosine-arabinoside-induced lung toxicity. 2009

Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000542 Alveolitis, Extrinsic Allergic A common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis. Allergic Alveolitis, Extrinsic,Hypersensitivity Pneumonitis,Pneumonitis, Hypersensitivity,Allergic Alveolitides, Extrinsic,Alveolitides, Extrinsic Allergic,Extrinsic Allergic Alveolitides,Extrinsic Allergic Alveolitis,Hypersensitivity Pneumonitides,Pneumonitides, Hypersensitivity
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D014057 Tomography, X-Ray Computed Tomography using x-ray transmission and a computer algorithm to reconstruct the image. CAT Scan, X-Ray,CT Scan, X-Ray,Cine-CT,Computerized Tomography, X-Ray,Electron Beam Computed Tomography,Tomodensitometry,Tomography, Transmission Computed,X-Ray Tomography, Computed,CAT Scan, X Ray,CT X Ray,Computed Tomography, X-Ray,Computed X Ray Tomography,Computerized Tomography, X Ray,Electron Beam Tomography,Tomography, X Ray Computed,Tomography, X-Ray Computer Assisted,Tomography, X-Ray Computerized,Tomography, X-Ray Computerized Axial,Tomography, Xray Computed,X Ray Computerized Tomography,X Ray Tomography, Computed,X-Ray Computer Assisted Tomography,X-Ray Computerized Axial Tomography,Beam Tomography, Electron,CAT Scans, X-Ray,CT Scan, X Ray,CT Scans, X-Ray,CT X Rays,Cine CT,Computed Tomography, Transmission,Computed Tomography, X Ray,Computed Tomography, Xray,Computed X-Ray Tomography,Scan, X-Ray CAT,Scan, X-Ray CT,Scans, X-Ray CAT,Scans, X-Ray CT,Tomographies, Computed X-Ray,Tomography, Computed X-Ray,Tomography, Electron Beam,Tomography, X Ray Computer Assisted,Tomography, X Ray Computerized,Tomography, X Ray Computerized Axial,Transmission Computed Tomography,X Ray Computer Assisted Tomography,X Ray Computerized Axial Tomography,X Ray, CT,X Rays, CT,X-Ray CAT Scan,X-Ray CAT Scans,X-Ray CT Scan,X-Ray CT Scans,X-Ray Computed Tomography,X-Ray Computerized Tomography,Xray Computed Tomography
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
CORNEAL TOXICITY OF CYTOSINE ARABINOSIDE.
October 1964, Archives of ophthalmology (Chicago, Ill. : 1960),
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Cytosine arabinoside-induced vasculitis.
March 1998, Mayo Clinic proceedings,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Cerebellar toxicity following high-dose cytosine arabinoside.
May 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Ocular toxicity from high-dose cytosine arabinoside.
February 1983, Cancer,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Cerebellar toxicity with high-dose cytosine arabinoside.
June 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Acute neurological toxicity of intrathecal cytosine arabinoside. A case report.
January 1986, Cancer chemotherapy and pharmacology,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
July 2000, Haematologica,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Cutaneous toxicity associated with high-dose cytosine arabinoside.
September 1992, Oncology nursing forum,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Thymineless death induced by cytosine arabinoside.
October 1968, Biochimica et biophysica acta,
Karine Chagnon, and Nicolas Boissel, and Emmanuel Raffoux, and Hervé Dombret, and Abdellatif Tazi, and Anne Bergeron
Cerebellar toxicity of cytosine arabinoside: clinical and neuropsychological signs.
October 2000, Neurology,
Copied contents to your clipboard!